Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Galvanizing plant science in Europe will depend on an overhaul of the tangle of indefensible regulations themselves, not on the advent of new plant breeding technologies that may escape existing rules.
By devoting funding to whole-genome studies, such as epigenetic and copy-number variation in stem cells, research on new genomic technology, and standards for methodologies and data collection/sharing, CIRM can spur both basic and translational research.
The NIH's proposed initiatives in translational science deserve solid financial backing from legislators and vocal support from the biomedical community.
